Dr Tuck-Kay Loke

Professional statement

Dr Tuck-Kay Loke is an esteemed consultant respiratory physician, who practises in Tunbridge Wells. With over 25 years of experience, Dr Loke is highly skilled in the diagnosis, treatment, and management of numerous pulmonary conditions, such as asthma, lung cancer, chronic obstructive pulmonary disease, allergy, sleep apnoea, and pulmonary fibrosis.  

Dr Loke graduated from Imperial College London with a bachelor of medicine and surgery in 1995. Upon completion of general medical training, he successfully became a member of the Royal College of Physicians in 1999. He went on to undertake specialist respiratory medicine training in numerous esteemed teaching hospitals, including Guy's and St Thomas' and St George's. In 2006, his research project on the pathogenesis of steroid-resistant asthma earned him a doctoral thesis from King's College London, thanks to a fellowship from the Guys and St Thomas’ Hospitals Charitable Foundation.

Dr Loke's NHS base has been Maidstone and Tunbridge Wells Trust since 2017. Previously, he spent a decade at Croydon Health Services NHS Trust. Here, he chaired the Trust Cancer Board and the Medicines Management Committee, as well as holding the position of CardioRespiratory Clinical Lead. He treats patients privately at the Nuffield Health Tunbridge Wells Hospital and the Spire Tunbridge Wells Hospital. He is interested in treating and managing various conditions and diagnosing lung cancer. He is a skilled bronchoscopist and EBUS operator.  

In addition to his clinical work, Dr Loke has an active interest in research and has worked as the the local principal investigator for many NIHR-accredited clinical studies on lung cancer. He has authored various peer-reviewed publications. He is a Fellow of the Royal College of Physicians and holds memberships in both the European Respiratory Society and British Thoracic Society. He has formerly been a member of the London Cancer Alliance's Thoracic Working Group and chaired the Southwest London Tumour Working Group for Lung Cancer.